FDA website to post names of drug makers blocking development of cheaper generics

May 17, 2018

The FDA plans to unveil a website today naming pharmaceutical companies that have blocked the development of generic drugs by failing to provide samples to competitors. This public posting is part of FDA Commissioner Scott Gottlieb's larger crackdown to, as he says, “end the shenanigans” by brand name drug companies.

Click the audio player above to hear the full story.